Earnings History Data for Emergent Biosolutions, Inc. (EBS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Emergent Biosolutions, Inc.

Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining the trust of their customers, employees and shareholders. The foundation of the corporate governance principles and practices are built on their reputation for openness, integrity and accountability. These are the principles that guide Emergent BioSolutions everyday. They have in place policies and practices to ensure that their Company is managed with integrity and in their shareholders' best interests. In addition, they are committed to meeting the requirements of federal and state law and the rules of the New York Stock Exchange.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
06-03-2024 AH EBS Emergent Biosolutions, Inc. 171.22 -0.77 -0.33 -0.31 Emergent Biosolutions Non-GAAP EPS of -$0.77 misses by $0.45, revenue of $276.6M beats by $2.6M
[3/6/2024 4:50 PM]		 2.77 -0.48 
(-14.88%)		 2.73 -0.53 
(-16.26%)		 1.42 - 13.67 4,812,791 4,100,000 101,300
11-12-2023 PM EBS Emergent Biosolutions 125.00 -1.44 -0.12 0.00 2.12 -0.37 
(-14.86%)		 0.0 0.0 
(0.00%)		 1.81 - 16.66 1,413,470 1,440,000 0
09-11-2023 PM EBS Emergent Biosolutions, Inc. 121.75 N/A 0.05 -1.27 Emergent Biosolutions reports Q3 results; updates FY23 guidance
[11/9/2023 3:41 AM]		 2.15 -0.06 
(-2.83%)		 2.21 0.0 
(0.00%)		 1.92 - 17.39 1,065,599 1,290,000 713
08-08-2023 AH EBS Emergent Biosolutions, Inc. 368.77 -1.06 -0.98 -0.86 Emergent Biosolutions Non-GAAP EPS of -$1.06 misses by $0.43, revenue of $337.9M beats by $121.15M
[8/8/2023 4:37 PM]		 5.91 -1.29 
(-17.99%)		 7.15 -0.05 
(-0.69%)		 5.53 - 30.94 4,869,929 1,630,000 6,529
09-05-2023 AH 4:15 PM ET
(May 9)		 EBS Emergent Biosolutions, Inc. 451.57 -3.17 -1.67 0.18 Emergent Biosolutions GAAP EPS of -$3.65, revenue of $165M
[5/9/2023 4:21 PM]		 10.72 1.03 
(10.57%)		 8.89 -0.81 
(-8.35%)		 7.74 - 40.45 2,493,005 1,190,000 17,890
27-02-2023 AH 4:15 PM ET
(Feb 27)		 EBS Emergent Biosolutions, Inc. 697.44 -0.31 0.31 4.50 Emergent Biosolutions Q4 results mixed, co guides FY 2023 revenue in-line
[2/27/2023 4:48 PM]		 12.39 -1.61 
(-11.46%)		 13.54 -0.46 
(-3.29%)		 10.61 - 45.14 2,415,126 1,540,000 9,542
08-11-2022 AH 4:05 PM ET
(Nov 8)		 EBS Emergent Biosolutions, Inc. 973.80 -1.27 -0.05 -0.36 Emergent Biosolutions Non-GAAP EPS of -$1.27 misses by $1.14, revenue of $240M misses by $26.35M; cuts FY22 outlook
[11/8/2022 4:24 PM]		 12.79 -6.93 
(-35.15%)		 17.00 -2.73 
(-13.84%)		 12.00 - 52.28 3,510,166 590,000 20,072
01-08-2022 AH 4:05 PM ET
(Aug 1)		 EBS Emergent Biosolutions, Inc. 1,570 -0.86 0.63 0.33 Emergent Biosolutions Non-GAAP EPS of -$0.86 misses by $1.26, revenue of $242.7M misses by $25.66M
[8/1/2022 4:17 PM]		 30.21 -4.02 
(-11.74%)		 33.94 -0.29 
(-0.85%)		 26.85 - 66.78 1,411,973 560,000 1,994
28-04-2022 AH 4:05 PM ET
(Apr 28)		 EBS Emergent Biosolutions, Inc. 1,870 0.18 0.23 1.53 Emergent Biosolutions Non-GAAP EPS of $0.18 beats by $0.11, revenue of $307.5M beats by $24.96M
[4/28/2022 4:11 PM]		 32.26 -4.36 
(-11.90%)		 33.75 -2.86 
(-7.81%)		 29.88 - 68.03 1,146,795 530,000 5,847
24-02-2022 AH 4:05 PM ET
(Feb 24)		 EBS Emergent Biosolutions, Inc. 2,270 4.50 3.88 3.67 Emergent Biosolutions Non-GAAP EPS of $4.50 beats by $0.08, revenue of $723.2M beats by $46.28M
[2/24/2022 4:14 PM]		 40.89 -1.45 
(-3.42%)		 42.34 0.0 
(0.00%)		 29.88 - 102.88 274,463 530,000 9,823
04-11-2021 AH 4:05 PM ET
(Nov 4)		 EBS Emergent Biosolutions, Inc. 2,680 -0.36 2.03 2.19 Emergent Biosolutions EPS misses by $2.64, misses on revenue
[11/4/2021 4:20 PM]		 33.76 -18.85 
(-35.83%)		 40.05 -12.56 
(-23.87%)		 29.88 - 127.20 6,869,394 390,000 26,624
29-07-2021 AH 4:05 PM ET
(Jul 29)		 EBS Emergent Biosolutions, Inc. 3,360 0.33 1.81 1.98 Emergent Biosolutions EPS misses by $1.23, misses on revenue
[7/29/2021 4:17 PM]		 65.97 0.75 
(1.15%)		 62.00 -3.22 
(-4.94%)		 55.07 - 137.61 715,321 490,000 3,297
29-04-2021 AH 4:05 PM ET
(Apr 29)		 EBS Emergent Biosolutions, Inc. 3,430 1.53 0.97 0.01 Emergent Biosolutions EPS beats by $0.36, misses on revenue
[4/29/2021 4:35 PM]		 60.84 -2.31 
(-3.66%)		 61.50 -1.65 
(-2.61%)		 60.70 - 137.61 835,432 1,140,000 2,851
18-02-2021 AH 4:05 PM ET
(Feb 18)		 EBS Emergent Biosolutions, Inc. 6,630 3.67 2.72 1.57 Emergent Biosolutions EPS beats by $0.26, beats on revenue
[2/18/2021 4:28 PM]		 102.94 -14.12 
(-12.07%)		 111.27 -5.79 
(-4.95%)		 46.37 - 137.61 1,980,724 440,707 4,959
05-11-2020 AH 4:25 PM ET
(Nov 5)		 EBS Emergent Biosolutions, Inc. 4,910 2.19 2.05 1.21 Emergent Biosolutions EPS beats by $0.04, misses on revenue, revised FY20 guidance
[11/5/2020 5:40 PM]		 92.04 -4.96 
(-5.11%)		 93.35 -3.65 
(-3.76%)		 46.37 - 137.61 685,634 484,972 4,178
30-07-2020 AH 4:10 PM ET
(Jul 30)		 EBS Emergent Biosolutions, Inc. 4,850 1.98 0.53 0.12 Emergent Biosolutions beats on revenue
[7/30/2020 4:39 PM]		 110.21 13.19 
(13.60%)		 104.03 7.01 
(7.23%)		 39.11 - 114.13 1,053,110 1,945,492 4,523